✦ LIBER ✦

Hypothesis: A nicotine-dopamine interaction linking smoking with Parkinson's disease and tardive dyskinesia

✍ Scribed by Darrell G. Kirch; Anna -Maria Alho; Richard Jed Wyatt

Book ID: 104899821
Publisher: Springer
Year: 1988
Tongue: English
Weight: 483 KB
Volume: 8
Category: Article
ISSN: 0272-4340
DOI: 10.1007/bf00711170

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fluoxetine-induced tardive dyskinesia in

Fluoxetine-induced tardive dyskinesia in a patient with Parkinson's disease

✍ Deshandra M. Raidoo 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 Dutch ⚖ 471 KB

Association of nicotine dependence susce

Association of nicotine dependence susceptibility gene, CHRNA5, with Parkinson's disease age at onset: Gene and smoking status interaction

✍ Lior Greenbaum; Amihai Rigbi; Nurit Lipshtat; Roberto Cilia; Silvana Tesei; Rosa 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 213 KB

GST polymorphisms, interaction with smok

GST polymorphisms, interaction with smoking and pesticide use, and risk for Parkinson’s disease in a Japanese population

✍ C. Kiyohara; Y. Miyake; M. Koyanagi; T. Fujimoto; S. Shirasawa; K. Tanaka; W. Fu 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 146 KB

A hypothesis on the pathophysiological m

A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: Implications for future strategies in treatment

✍ Dr. A. R. Crossman 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 843 KB

## Abstract Long‐term treatment of human Parkinson's disease with levodopa or dopamine agonists is often complicated by the appearance of abnormal involuntary movements (dyskinesias) that are extremely difficult to control. Little is known of the cause, pathophysiological mechanisms, or possible st

Differential interaction of competitive

Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease

✍ Peter-Andreas Löschmann; Ullrich Wüllner; Michael T. Heneka; Jörg B. Schulz; Mar 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 3 views

1-aminomethyl-5,6-dihydroxy-3-phenylisochroman; NMDA antagonist; CPP; 3-((6)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid

Differential cytotoxicity of dopamine an

Differential cytotoxicity of dopamine and H2O2 in a human neuroblastoma divided cell line transfected with α-synuclein and its familial Parkinson's disease-linked mutants

✍ Christophe Wersinger; Anita Sidhu 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 180 KB